Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 223.61M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -67.33M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -7.00% |
| Sales | 4.11M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -11.00% |
| Dividend | N/A | Price/Book | 13.93 | EPS next 5Y | - | 52W High Chg | -33.00% |
| Recommedations | - | Quick Ratio | 2.46 | Shares Outstanding | 19.21M | 52W Low Chg | 12.00% |
| Insider Own | 11.18% | ROA | -127.62% | Shares Float | 13.60M | Beta | 0.75 |
| Inst Own | 34.15% | ROE | -329.00% | Shares Shorted/Prior | -/- | Price | 13.25 |
| Gross Margin | 61.23% | Profit Margin | - | Avg. Volume | 356 | Target Price | - |
| Oper. Margin | -2,250.30% | Earnings Date | - | Volume | 30 | Change | 0.00% |
About ANTERIS TECHNOLOGIES LTD
Anteris Technologies Ltd, a structural heart company, designs, develops, and commercializes medical devices. The company manufactures and sells ADAPT, a regenerative tissue product. Its lead product is the DurAVRTM, a transcatheter heart valve for the treatment of aortic stenosis. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.
ANTERIS TECHNOLOGIES LTD News